LODH Immunology Fund

LODH Immunology Fund

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Switzerland, Geneva

About

The VC's location is in Europe, Switzerland. The the headquarters of this Corporate Investor is in Geneva.

The fund usually invests in rounds together with 4-5 others. Besides LODH Immunology Fund, start-ups are typically funded by Reference Capital SA, Novartis Venture Fund, Pictet Private Equity Investors S.A.. The most common co-investors for the fund are Novartis Venture Fund, Pictet Private Equity Investors S.A., Index Ventures and also 2 different VCs. The investors in the following rounds are usually Novartis Venture Fund, BZ Bank, VI Partners AG, and 11 VCs in total.

Also, a start-up has to be aged 2-3 years to expect investment from this fund. The fund has specific requirements for the number of founders in a start-up. The country of its establishment and the country of its most frequent investments doesn't coincide - Denmark. However, start-ups from 1 other country can be found in the fund's portfolio. Among the most popular portfolio start-ups of the fund, are Genmab, 7TM Pharma, ESBATech. Among the most popular investment industries for the fund are Health Care, Therapeutics. However, the fund’s focus is not limited to this, since there are 3 more areas of investment.

The most common rounds for this fund are in the range of 10 - 50 millions dollars. We recorded the biggest number of exits for this fund in 2019. In terms of the fund's performance, this Corporate Investor has 3 percentage points less exits when compared to other organizations. In comparison with other funds, LODH Immunology Fund makes 4 percentage points more than the average number of lead investments. The fund's activity peaked in 2000. The fund typically enters into less than 2 deals annually.

Fund Activity

Not operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: lodhagroup.com; User name format in descending order of probability: first '.' last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

16.7% of cases

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]

1

Funds Investing in Following
Rounds

Novartis Venture Fund, BZ Bank, VI Partners AG

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: